- 基本信息
导师姓名:
|
钟来平
|
学科代码:
|
100302
|
|
性别:
|
男
|
学科名称:
|
口腔临床医学
|
培养单位:
|
口腔医学院
|
三级学科
|
|
导师类型:
|
博士生导师
|
专业领域名称:
|
口腔医学 专业学位
|
联系方式:
|
上海市黄浦区制造局路639号1号楼13楼
|
专业领域代码:
|
105200
|
邮编:
|
200011
|
邮箱地址:
|
zhonglaiping@163.com
|
- 研究方向 (点击浏览详细信息)
- 社会任职
|
美国临床肿瘤协会会员
|
中国临床肿瘤学会转化医学专委会委员
|
《Journal of Oral Pathology and Medicine》Reviewer
|
《Scientific Reports》Reviewer
|
中华口腔医学会会员、口腔颌面头颈肿瘤专委会委员
|
《Molecular and Cellular Biochemistry》Reviewer
|
《Advances in Modern Oncology Research》Editorial Board Member
|
《Annals of Hematology and Oncology》Editorial Board Member
|
中国临床肿瘤学会头颈肿瘤专委会常委
|
《BMC Oral Health》Reviewer
|
《Oral Oncology》Reviewer
|
《Oral Diseases》Reviewer
|
《Oncology Reports》Reviewer
|
上海市头颈肿瘤诊治和转化医学中心秘书长
|
国家自然科学基金评审专家
|
《Archive of Oral Biology》Reviewer
|
上海市口腔医学会会员、口腔基础医学专委会委员、口腔颌面头颈肿瘤专委会委员、口腔颌面科专委会青年委员
|
亚洲口腔颌面外科医师协会会员
|
国际口腔颌面外科医师协会会员
|
《Journal of Cell Biology and Genetics》Reviewer
|
中国生物工程学会转化医学分会委员
|
《Annuals of Otolaryngology》Editorial Board Member
|
《European Journal of Surgical Oncology》Reviewer
|
《India Journal of Dental Research》Reviewer
|
中国医疗保健国际交流促进会肿瘤整形外科与功能性外科分会委员
|
《Head Neck》Reviewer
|
《Pathology-Research and Practice》Reviewer
|
《Archives of Otolaryngology and Rhinology》Editorial Board Member
|
- 科研项目
82172734 | IFNγ通过IRF1和2/7不同途径调控PD-L1介导的口腔鳞癌细胞免疫逃逸的机制研究 | 国家自然基金委,面上项目 |
2022-01~2025-12
|
55万元
| 课题负责人 |
21Y21900300 | 生物标志物指导口腔鳞癌个体化诱导治疗的临床研究 | 上海市科委,重点项目 |
2021-10~2024-09
|
100万元
| 课题负责人 |
YBKB202111 | 诱导治疗局部晚期口腔鳞癌样本库 | 上海交通大学医学院附属第九人民医院 |
2021-09~2024-08
|
25万元
| 课题负责人 |
201916 | 口腔/口咽鳞癌个体化诊疗团队 | 上海九院临床研究型MDT项目 |
2020-01~2022-12
|
45万元
| 课题负责人 |
20191915 | 研究型医师 | 上海交大医学院双百人计划 |
2020-01~2022-12
|
100万元
| 课题负责人 |
81972525 | ErbB2和重组GDF15在GDF15指导口腔鳞癌个体化治疗中的机制研究 | 国家自然科学基金,面上项目 |
2020-01~2023-12
|
54万元
| 课题负责人 |
19XD1422300 | 外源性GDF15抑制口腔鳞癌进展的分子机制研究 | 上海市科委,优秀学术带头人计划 |
2019-01~2021-12
|
40万元
| 课题负责人 |
2018BR41 | 生物标志物指导口腔鳞癌个体化治疗的转化研究 | 上海市卫计委,优秀学科带头人计划 |
2018-07~2021-06
|
45万元
| 课题负责人 |
17SG18 | Stathmin在口腔鳞癌TPF诱导化疗中的转化研究 | 上海市教委,曙光计划 |
2018-01~2020-12
|
15万元
| 课题负责人 |
SHDC12017X02 | Stathmin指导口腔鳞癌TPF诱导化疗的II期临床试验 | 上海市申康中心 |
2017-12~2020-11
|
30万元
| 课题负责人 |
81672660 | Stathmin 1在口腔鳞癌诱导化疗及p53、PI3K/AKT信号通路中的机制研究 | 国家自然科学基金面上项目 |
2017-01~2020-12
|
57万元
| 课题负责人 |
Y-MT2015-036 | EGFR突变在口腔/口咽鳞癌西妥昔单抗联合TP诱导化疗临床试验中的研究 | 中国临床肿瘤协会
|
2015-10~2017-10
|
5万元
| 课题负责人 |
15ZH2008 | GDF15在口腔鳞癌个体化治疗中的转化医学研究 | 上海交通大学医学院转化医学创新基金 |
2015-06~2017-05
|
20万元
| 课题负责人 |
81472519 | GDF15在口腔鳞癌TPF诱导化疗和调控AKT/ERK信号通路中的机制研究 | 国家自然科学基金面上项目 |
2015-01~2018-12
|
80万元
| 课题负责人 |
201447 | 生物标志物指导口腔/口咽鳞癌个体化治疗方案选择的转化医学研究 | 上海市人力资源和社会保障局 |
2014-12~2016-12
|
10万元
| 课题负责人 |
13QH1401700 | Annexin A1与病理分化程度对口腔鳞癌诱导化疗的影响及其机制研究 | 上海市科委 |
2013-09~2015-08
|
15万元
| 课题负责人 |
81272979 | Annexin A1在头颈鳞癌EGF相关ERK/MAPK信号通路中的作用机制 | 国家自然科学基金,面上项目 |
2013-01~2016-12
|
65万元
| 课题负责人 |
10140902200 | 建立基于口腔鳞癌体外细胞癌变模型的动物模型 | 上海市科委,动物专项 |
2010-05~2012-03
|
20万元
| 课题负责人 |
1052nm04700 | 血清多肽的纳米磁珠质谱在口腔癌早期诊断中的研究 | 上海市科委,纳米专项 |
2010-03~2012-06
|
30万元
| 课题负责人 |
30973344 | 口腔鳞癌发生发展中GDF15与p53、ERK1/2信号通路作用关系的研究 | 国家自然基金委,面上项目 |
2010-01~2012-12
|
31万元
| 课题负责人 |
08QA1405600 | 膜联蛋白A1在口腔鳞癌发生发展中的机制研究 | 上海市科委,启明星计划 |
2008-07~2010-07
|
15万元
| 课题负责人 |
30700953 | IGFBP3及相关基因在口腔上皮细胞恶性转化中作用的研究 | 国家自然基金委,青年基金 |
2008-01~2010-12
|
17万元
| 课题负责人 |
2007CG22 | 应用比较蛋白质组学筛选口腔黏膜上皮癌变相关蛋白的研究 | 上海市教委,晨光计划 |
2007-11~2009-12
|
6万元
| 课题负责人 |
20060400168 | 应用比较蛋白质组学筛选口腔鳞癌形成过程中的肿瘤标志物 | 中国博士后科学基金委 |
2006-12~2008-12
|
5万元
| 课题负责人 |
- 学术论文
Zhao TC, Zhou ZH, Ju WT, Liang SY, Tang X, Zhu DW, Zhang ZY,
|
Mechanism of sensitivity to TPF chemoagents and its potential alternative of erbB2 in oral cancer with GDF15 overexpression
|
Cancer Sci
|
2022
|
113(2):478-488
|
Zhong J, Zhou Z, Hu Y, Zhao T, Yao Y,, Zhu D
|
Diagnosis and management of hypoglossal nerve-derived schwannoma in the floor of mouth: a case series
|
BMC Oral Health
|
2022
|
22(1):265
|
Zhao TC, Zhou ZH, Ju WT, Liang SY, Tang X, Zhu DW, Zhang ZY,
|
Mechanism of sensitivity to TPF chemoagents and its potential alternative of erbB2 in oral cancer with GDF15 overexpression
|
Cancer Sci
|
2022
|
113(2):478-488
|
Zhao TC, Liang SY, Zhou ZH, Ju WT, Zhang ZY, Zhu DW,
|
Targeting ERK combined with apatinib may be a promising therapeutic strategy for treating oral squamous cell carcinoma
|
Am J Cancer Res
|
2021
|
11(6): 2960-2974
|
Zhou ZH, Liang SY, Zhao TC, Cao XK, Qi M, Huang YY, Ju WT, Yang M, Zhu DW, Peng YC,
|
Overcoming chemotherapy resistance using pH-sensitive hollow MnO2 nanoshells that target the hypoxic tumor microenvironment of metastasized oral squamous cell carcinoma
|
J Nanobiotechnology
|
2021
|
19(1): 157
|
Zhou ZH, Zhao TC, Liang SY, Zhang ZY, Zhu DW, Ju WT,
|
A?therapeutic approach?with?combination of interferon-gamma?and autophagy inhibitor?for?oral?squamous?cell?carcinoma
|
Am J Cancer Res
|
2021
|
11(4): 1503-1521
|
Liang SY, Zhao TC, Zhou ZH, Ju WT, Liu Y, Tan YR, Zhu DW, Zhang ZY,
|
Anti-tumour effect of Carrimycin on oral squamous cell carcinoma cells in vitro and in vivo
|
Transl Oncol
|
2021
|
14(6): 101074
|
Ju WT, Liu Y, Wang LZ, Li J, Ren GX, Sun J, Tu WY, Hu YJ, Ji T, Yang WJ, Li J, He Y, Wang YA, Zhang CP,, Zhang ZY
|
Phase III trial of docetaxel cisplatin 5-fluorouracil induction chemotherapy for resectable oral cancer suggests favorable pathological response as a surrogate endpoint for good therapeutic outcome
|
Cancer Commun
|
2021
|
41(3): 279-283
|
Liu Y, Fan BH, Tan YR, Zhu DW, Dong MJ, Wang LZ, Li J, Sun J, Zhang CP, Ji T, Yang WJ, Abdelrehem A, Wu YQ,
|
Diffuse-type tenosynovial giant cell tumor of the temporomandibular joint with skull base invasion: a report of 22 cases with literature review
|
Or Surg Or Med Or Pa
|
2021
|
131(1): 16-26
|
Sun W, Zhao T, Aladelusi TO, Ju W, Zhang Z,, Zhu D
|
Decreased Annexin A1 expression enhances sensitivity to docetaxel, cisplatin and 5-fluorouracil combination induction chemotherapy in oral squamous cell carcinoma
|
J Oral Pathol Med
|
2021
|
50(8): 795-802
|
Ju WT, Ma HL, Zhao TC, Liang SY, Liu Y, Tan YR, Zhu DW, Wang LZ, Li J, Zhang ZY, Zhou G,
|
Stathmin guides personalized therapy in oral squamous cell carcinoma
|
Cancer Sci
|
2020
|
111(4): 1303-1313
|
Liu Y, Fan BH, Tan YR, Zhu DW, Dong MJ, Wang LZ, Li J, Sun J, Zhang CP, Ji T, Yang WJ, Abdelrehem A, Wu YQ,
|
Diffuse-type tenosynovial giant cell tumor of the temporomandibular joint with skull base invasion: a report of 22 cases with literature review
|
Oral Surg Oral Med Oral Pathol Oral Radiol
|
2020
|
accepted
|
Zhao TC, Liang SY, Fu Y, Ju WT, Zhou ZH, Wang LZ, Li J, Zhang CP, Zhang ZY,
|
High-risk lymph node ratio predicts worse prognosis in patients with locally advanced oral cancer
|
J Oral Pathol Med
|
2020
|
in press
|
Hu YJ, Sun WW, Zhao TC, Liu Y, Zhu DW, Wang LZ, Li J, Zhang CP, Zhang ZY,
|
Cyclin D1 overexpression enhances chemosensitivity to TPF chemotherapeutic agents via caspase-3 pathway in oral cancer
|
Oncol Lett
|
2020
|
in press
|
Yin XL, Tan YR, Liu Y, Sun WW, Zhang XY, Hu YJ, Sun J, Zhang CP,
|
Clinical application of temporary external fixator for immediate mandibular reconstruction
|
J Craniofac Surg
|
2019
|
30(4): e337-e342
|
Ju WT, Zhao TC, Liu Y, Tan YR, Sun WW, Dong MJ, Sun Q, Wang LZ, Li J,
|
Computed tomographic features of adenoid cystic carcinoma in the palate
|
Cancer Imaging
|
2019
|
19(1): 3
|
Zhao TC, Liang SY, Ju WT, Liu Y, Tan YR, Zhu DW, Zhang CP, Zhang ZY,
|
Normal BMI predicts the survival benefits of inductive docetaxel, cisplatin, and 5-fluorouracil in patients with locally advanced oral squamous cell carcinoma
|
Clin Nutr
|
2019
|
in press
|
Liu Y, Tan YR, Sun WW, Ju WT, Fu Y, Wang LZ, Li J, Zhang CP, Zhang ZY,
|
Identification of SCARA5 as a potential biomarker for oral squamous cell carcinoma through MALDI TOF MS analysis
|
Proteom Clin Appl
|
2018
|
12(5): e17001800
|
Ju WT, Fu Y, Liu Y, Tan YR, Dong MJ, Wang LZ, Li J,
|
Clinical and pathological analyses of tuberculosis in the oral cavity: report of 11 cases
|
Oral Surg Oral Med Oral Pathol Oral Radiol
|
2018
|
125(1): 44-51
|
Ma J, Fu Y, Tu YY, Liu Y, Tan YR, Ju WT, Pickering CR, Myers JN, Zhang ZY,
|
Mutation allele frequency threshold does not affect prognostic analysis using next-generation sequencing in oral squamous cell carcinoma
|
BMC Cancer
|
2018
|
18:758
|
Tang X, Hu YJ, Ju WT, Fu Y, Sun WW, Liu Y, Tan YR, Wang LZ, Li J, Tu YY, Zhang CP, Zhang ZY,
|
Elevated GDF15 expression predicts long-term benefit of TPF induction chemotherapy in patients with oral cancer
|
Oncol Lett
|
2018
|
15(5): 8118-8124
|
Ma HL, Jin SF, Ju WT, Fu Y, Tu YY, Wang LZ, Li J, Zhang ZY,
|
Stathmin is overexpressed and regulated by mutant p53 in oral squamous cell carcinoma
|
J Exp Clin Cancer Res
|
2017
|
36:109
|
Ma J, Tang X, Sun WW, Liu Y, Tan YR, Ma HL, Zhu DW, Wang M, Wang LZ, Li J, Tu YY, Zhang CP, Zhang ZY,
|
Mutant GDF15 presents a poor prognostic outcome for patients with oral squamous cell carcinoma
|
Oncotarget
|
2016
|
7(2): 2113-2122
|
, Zhang CP, Ren GX, Guo W, William Jr WN, Hong CS, Sun J, Zhu HG, Tu WY, Li J, Cai YL, Yin QM, Wang LZ, Wang ZH, Hu YJ, Ji T, Yang WJ, Ye WM, Li J, He Y, Wang YA, Xu LQ, Zhuang ZP, Lee JJ, Myers JN, Zhang ZY
|
Long-term results of a randomized phase III trial of TPF induction chemotherapy followed by surgery and radiation in locally advanced oral squamous cell carcinoma
|
Oncotarget
|
2015
|
6(21): 18707-18714
|
Ma HL, Yu C, Liu Y, Tan YR, Qiao JK, Yuan YX, Wang LZ, Li J, Chen Q, Chen FX, Zhang ZY,
|
Decreased expression of glutathione S-transferase pi correlates with poorly differentiated grade in patients with oral squamous cell carcinoma
|
J Oral Pathol Med
|
2015
|
44(3): 193-200
|
Liu Y, Li J, Tan YR, Xiong P,
|
Accuracy of diagnosis of salivary gland tumors with the use of ultrasonography, computed tomography, and magnetic resonance imaging: a meta-analysis
|
Oral Surg Oral Med Oral Pathol Oral Radiol
|
2015
|
119(2): 238-245.
|
Zhu DW, Yuan YX, Qiao JK, Yu C, Yang X, Wang LZ, Zhang ZY,
|
Enhanced anticancer activity of a protein phosphatase 2A inhibitor on chemotherapy and radiation in head and neck squamous cell carcinoma
|
Cancer Lett
|
2015
|
356(2): 773-780
|
Ye G, Liu Y, Yin P, Zeng Z, Huang Q, Kong H, Lu X,, Zhang Z, Xu G
|
Study of induction chemotherapy efficacy in oral squamous cell carcinoma using pseudotargeted metabolomics
|
J Proteome Res
|
2014
|
13(4): 1994-2004
|
Zhu DW, Tan YR, Yang X, Qiao JK, Yu C, Wang LZ, Li J, Zhang ZY,
|
Phospholipase C gamma 1 is a potential prognostic biomarker for patients with locally advance and resectable oral squamous cell carcinoma
|
Int J Oral Maxillofac Surg
|
2014
|
43(12): 1418-1426
|
Yang CZ, Ma J, Luo QQ, Neskey DM, Zhu DW, Liu Y, Myers JN, Zhang CP, Zhang ZY,
|
Elevated level of serum growth differentiation factor 15 is associated with precancerous oral mucosal lesions and oral squamous cell carcinoma
|
J Oral Pathol Med
|
2014
|
43(1): 28-34
|
Yang CZ, Ma J, Zhu DW, Liu Y, Montgomery B, Wang LZ, Li J, Zhang ZY, Zhang CP,
|
GDF15 is a potential predictive biomarker for TPF induction chemotherapy and promotes tumorigenesis and progression in oral squamous cell carcinoma
|
Ann Oncol
|
2014
|
25(6): 1215-1222
|
Zhu DW, Yang X, Yang CZ, Ma J, Liu Y, Yan M, Wang LZ, Li J, Zhang CP, Zhang ZY,
|
Annexin A1 down-regulation in oral squamous cell carcinoma correlates to pathologic differentiation grade
|
Oral Oncol
|
2013
|
49(6):542-550
|
Zhu DW, Liu Y, Yang X, Yang CZ, Ma J, Yang X, Qiao JK, Wang LZ, Li J, Zhang CP, Zhang ZY,
|
Low Annexin A1 expression predicts benefit from induction chemotherapy in oral cancer patients with moderate or poor pathologic differentiation grade
|
BMC Cancer
|
2013
|
13(1): 301
|
Ma J, Liu Y, Yang X, Zhang CP, Zhang ZY,
|
Induction chemotherapy in patients with resectable head and neck squamous cell carcinoma: a meta-analysis
|
World J Surg Oncol
|
2013
|
11(1): 67
|
, Zhang CP, Ren GX, Guo W, William Jr WN, Sun J, Zhu HG, Tu WY, Li J, Cai YL, Wang LZ, Fang XD, Wang ZH, Hu YJ, Ji T, Yang WJ, Ye WM, Li J, He Y, Wang YA, Xu LQ, Wang BS, Kies MS, Lee JJ, Myers JN, Zhang ZY
|
Randomized phase III trial of induction chemotherapy with docetaxel, cisplatin and fluorouracil followed by surgery versus up-front surgery in locally advanced resectable oral squamous cell carcinoma
|
J Clin Oncol
|
2013
|
31(6):744-751
|
, Zhu DW, William Jr. WN, Liu Y, Ma J, Yang CZ, Yang X, Wang LZ, Li J, Myers JN, Lee JJ, Zhang CP, Zhang ZY
|
Elevated cyclin D1 expression is predictive for a benefit from TPF induction chemotherapy in oral squamous cell carcinoma patients with advanced nodal disease
|
Mol Cancer Ther
|
2013
|
12(6):1112-1121
|
, Zhang ZY
|
Neoadjuvant versus induction chemotherapy: more than semantics reply
|
J Clin Oncol
|
2013
|
31(23):2972-2973
|
, Ow A, Yang WJ, Hu YJ, Wang LZ, Zhang CP
|
Surgical management of solitary venous malformation in the mid-cheek region
|
Oral Surg Oral Med Oral Pathol Oral Radiol
|
2012
|
114(2):160-166
|
Yang X, Ow A, Zhang CP, Wang LZ, Yang WJ, Hu YJ,
|
Clinical analysis of 120 cases of intraoral lymphoepithelial cyst
|
Oral Surg Oral Med Oral Pathol Oral Radiol
|
2012
|
113(4):448-452
|
Ma J, Liu Y, Huang XL, Zhang ZY, Myers JN, Neskey DM,
|
Induction chemotherapy decreases the rate of distant metastasis in patients with head and neck squamous cell carcinoma but does not improve survival or locoregional control: a meta-analysis
|
Oral Oncol
|
2012
|
48(11):1076-1084
|
, Zhang ZY, Zhu HG, Fu HH, He Y
|
Clinical management of peripheral ameloblastoma
|
J Craniofac Surg
|
2011
|
22(5):1929-1932
|
Yang X, Ji T, Wang LZ, Yang WJ, Hu YJ,, Zhang CP, Zhang ZY
|
Clinical analysis of masses arising from the accessory parotid gland
|
Oral Surg Oral Med Oral Pathol Oral Radiol Endod
|
2011
|
112(3):291-298
|
, Wang LZ, Ji T, Yang WJ, Zhang CP
|
Management of facial nerve schwannoma in the accessory parotid region
|
J Oral Maxillofac Surg
|
2011
|
69(5):1390-1397
|
Yang X, Wei KJ, Zhang L, Pan HY, Zhou XJ,, Li J, Chen WT, Zhang ZY
|
Increased expression of Cathepsin B in oral squamous cell carcinoma
|
Int J Oral Maxillofac Surg
|
2010
|
39(2):174-181
|
Jiang Q, Pan HY, Ye DX, Zhang P,, Zhang ZY
|
Downregulation of tapasin expression in primary human oral squamous cell carcinoma: association with clinical outcome
|
Tumor Biol
|
2010
|
31(5):451-459
|
, Wei KJ, Yang X, Pan HY, Wang LZ, Zhang ZY
|
Overexpression of Galectin-1 is positively correlated with pathologic differentiation grade in oral squamous cell carcinoma
|
J Cancer Res Clin Oncol
|
2010
|
136(10):1527-1535
|
, Wang LZ, Ji T, Hu YJ, Ye WM, Li J, Sun J, Zhu HG, Li Jiang, Zhang CP
|
Clinical analysis of Castleman disease hyaline vascular type in parotid and neck region
|
Oral Surg Oral Med Oral Pathol Oral Radiol Endod
|
2010
|
109(3):432-440
|
Yu ZW,, Ji T, Zhang P, Chen WT, Zhang CP
|
MicroRNAs contribute to the chemoresistance of cisplatin in tongue squamous cell carcinoma lines
|
Oral Oncol
|
2010
|
46(4):317-322
|
Yang X, Wei KJ, Zhang L, Pan HY, Ye DX,, Zhang ZY
|
Decreased expression of S100A6 in oral squamous cell carcinoma
|
Oncol Rep
|
2010
|
24(2):479-488
|
Yang X, Ren GX, Zhang CP, Zhou GY, Hu YJ, Yang WJ, Guo W, Li J,
|
Neck dissection and post-operative chemotherapy with dimethyl triazeno imidazole carboxamide and cisplatin protocol are useful for oral mucosal melanoma
|
BMC Cancer
|
2010
|
10(1):623-623
|
, Zhang L, Yang X, Pan HY, Zhou XJ, Wei KJ, Ye DX, Jiang Q, Chen WT, Zhang ZY
|
Comparative proteomic analysis of differentially expressed proteins in an in vitro cellular carcinogenesis model of oral squamous cell carcinoma
|
Proteomics Clin Appl
|
2009
|
3(3):322-337
|
Zhang L, Yang X, Pan HY, Li JZ, Zhou XJ, Li J, Chen WT,, Zhang ZY
|
Expression of growth differentiation factor 15 is positively correlated with histopathological malignant grade and in vitro cell proliferation in oral squamous cell carcinoma
|
Oral Oncol
|
2009
|
45(7):627-632
|
Zhang L, Yang X,, Zhou XJ, Pan HY, Wei KJ, Li J, Chen WT, Zhang ZY
|
Decreased expression of Annexin A1 correlates with pathologic differentiation grade in oral squamous cell carcinoma
|
J Oral Pathol Med
|
2009
|
38(4):362-370
|
Wei KJ, Zhang L, Yang X,, Zhou XJ, Pan HY, Li J, Chen WT, Zhang ZY
|
Overexpression of cytokeratin 17 protein in oral squamous cell carcinoma in vitro and in vivo
|
Oral Dis
|
2009
|
19(1):111-117
|
, Wei KJ, Yang X, Zhang L, Zhou XJ, Pan HY, Li J, Chen WT, Zhang ZY
|
Increased expression of Annexin A2 in oral squamous cell carcinoma
|
Arch Oral Biol
|
2009
|
54(1):17-25
|
, Zheng JW, Zhang WL, Zhang SY, Zhu HG, Ye WM, Wang YA, Zhang ZY
|
Multicentric Gorham disease in the oral and maxillofacial region: report of a case and review of the literature
|
J Oral Maxillofac Surg
|
2008
|
66(5):1073-1076
|
Zhang CP,, Hu YJ, Zhang ZY
|
Three-flap reconstruction of a large defect caused by radical resection of advanced oral cancer
|
J Oral Maxillofac Surg
|
2008
|
66(6):1269-1277
|
, Yang X, Zhang L, Wei KJ, Pan HY, Zhou XJ, Li J, Chen WT, Zhang ZY
|
Overexpression of insulin-like growth factor binding protein 3 in oral squamous cell carcinoma
|
Oncol Rep
|
2008
|
20(6):1441-1447
|
, Pan HY, Zhou XJ, Ye DX, Zhang L, Yang X, Chen WT, Zhang ZY
|
Characteristics of a cancerous cell line, HIOEC-B(a)P-96, induced by benzo(a)pyrene from human immortalized oral epithelial cell line
|
Arch Oral Biol
|
2008
|
53(5):443-452
|
Zheng JW,, Zhang ZY, Zhang CP, Zhu HG, Sun J, Fan XD, Hu YJ, Ye WM, Li J, Suen J
|
Carotid artery resection and reconstruction: A clinical experience on 28 consecutive cases
|
Int J Oral Maxillofac Surg
|
2007
|
36(6):514-521
|
, Li J, Zhang CP, Zhu HG, Sun J, Zhang ZY
|
Expression of E-cadherin in cervical lymph nodes from primary oral squamous cell carcinoma patients
|
Arch Oral Biol
|
2007
|
52(8):740-747
|
, Zhu HG, Zhang CP, Chen WT, Zhang ZY
|
Detection of serum Cyfra 21-1 in patients with primary oral squamous cell carcinoma
|
Int J Oral Maxillofac Surg
|
2007
|
36(3):230-234
|
, Zhang CP, Li J, Chen WT, Zhang ZY
|
Increase of Cyfra 21-1 concentration in saliva from oral squamous cell carcinoma patients
|
Arch Oral Biol
|
2007
|
52(11):1079-1087
|
, Chen WT, Zhang CP, Zhang ZY
|
Increased CK19 expression correlated with pathological differentiation grade and prognosis in oral squamous cell carcinoma patients
|
Oral Surg Oral Med Oral Pathol Oral Radiol Endod
|
2007
|
104(3):377-384
|
, Zhao SF, Chen GF, Ping FY, Xu ZF, Hu JA
|
Increase of CK19 mRNA level in oral squamous cell carcinoma tissues detected by relative quantification with real-time PCR technique
|
Arch Oral Biol
|
2006
|
51(12):1112-1119
|
Chen GF,
|
Functional reconstruction of maxilla with Titanium mesh and pedicled buccal fat pad flap
|
Plast Reconstr Surg
|
2005
|
115(1):334-336
|
, Chen GF, Xu ZF, Zhang X, Ping FY, Zhao SF
|
Detection of telomerase activity in saliva from oral squamous cell carcinoma patients
|
Int J Oral Maxillofac Surg
|
2005
|
34(5):566-570
|
, Chen GF, Zhao SF
|
Cervical Castleman disease in children
|
Br J Oral Maxillofac Surg
|
2004
|
42(1):69-71
|
, Zhao SF, Chen GF, Ping FY
|
Ultrasonographic appearance of lipoma in oral and maxillofacial region
|
Oral Surg Oral Med Oral Pathol Oral Radiol Endod
|
2004
|
98(6):738-740
|
, Chen GF, Fan LJ, Zhao SF
|
Immediate reconstruction of maxilla with bone grafts supported by pedicled buccal fat pad graft
|
Oral Surg Oral Med Oral Pathol Oral Radiol Endod
|
2004
|
97(2):147-154
|
, Chen GF
|
Chondroblastoma of the temporomandibular region: report of 3 cases
|
Chin Med J
|
2003
|
116(10):1591-1593
|
Chen GF,
|
A bilateral musculomucosal buccal flap method for cleft palate surgery
|
J Oral Maxillofac Surg
|
2003
|
61(12):1399-1404
|
|